HSV-1 can cause genital herpes. While most people associate HSV-1 with cold sores on the mouth and HSV-2 with genital infections, the reality is that either virus can infect either location. HSV-1 is now a significant cause of genital herpes, primarily spread through oral sex when someone with an oral HSV-1 infection passes the virus to a partner’s genitals.
How HSV-1 Reaches the Genitals
The most common route is oral sex. When someone carries HSV-1 in or around their mouth, they can transmit it to a partner’s genital area during oral contact. This can happen even without visible cold sores, because the virus periodically “sheds” from the skin’s surface with no symptoms at all. Contact with saliva, skin around the mouth, or an active cold sore can all lead to transmission.
This pattern has become increasingly common. The World Health Organization estimated that 376 million people worldwide had genital HSV-1 infections as of 2020, a number that has risen compared to earlier estimates. The shift is partly driven by a generational change: fewer children are catching HSV-1 orally during childhood (likely due to less crowded living conditions and better hygiene), which means more people reach adulthood without any prior exposure to the virus. Without existing immunity from a childhood oral infection, they’re susceptible to catching HSV-1 genitally when they become sexually active.
Symptoms of Genital HSV-1
A first outbreak of genital HSV-1 looks much like genital HSV-2. You may notice small blisters or open sores on or around the genitals, along with itching, tingling, or burning in the area. Some people experience flu-like symptoms during the initial episode, including body aches and swollen lymph nodes near the groin. The first outbreak is typically the most painful and can last two to three weeks.
Before sores appear, many people feel warning signs called prodromal symptoms: tingling or pinching sensations in the affected area, muscle tenderness, shooting pains in the buttocks or legs, or nerve pain running down the leg. Recognizing these signals can help you avoid sexual contact during periods when you’re most likely to transmit the virus.
How Recurrences Compare to HSV-2
This is where genital HSV-1 and genital HSV-2 diverge in a meaningful way. HSV-1 strongly prefers the oral region, so when it ends up in the genitals, it tends to reactivate far less often. People with genital HSV-1 typically experience fewer outbreaks per year, and those outbreaks tend to become less frequent over time more quickly than with HSV-2. Many people with genital HSV-1 have one initial outbreak and then rarely, if ever, have another.
Genital HSV-2, by contrast, recurs more frequently because that virus is better adapted to the nerve pathways serving the genital area. On average, HSV-2 causes several outbreaks in the first year, tapering gradually. The lower recurrence rate of genital HSV-1 also means less asymptomatic shedding, which translates to a lower (though not zero) risk of passing the virus to partners between outbreaks.
Getting the Right Diagnosis
Knowing whether your genital herpes is caused by HSV-1 or HSV-2 matters for understanding your likely course of infection, recurrence patterns, and transmission risk. A visual exam alone can’t distinguish between the two. The most reliable approach is a swab test taken directly from an active sore. Nucleic acid amplification tests (a type of molecular swab test) are the most sensitive option and can identify exactly which virus type is present. The swab works best on fresh blisters or sores that haven’t started crusting over.
Blood tests can detect antibodies to HSV-1 or HSV-2, but they have limitations. A positive HSV-1 blood test tells you that you carry the virus somewhere in your body. It can’t tell you whether the virus is oral, genital, or both. That’s why swab testing during an active outbreak is the preferred method for pinpointing the location of infection.
Treatment and What to Expect
Genital HSV-1 is treated with the same antiviral medications used for genital HSV-2. These medications shorten outbreaks, reduce their severity, and lower the chance of passing the virus to a partner. For a first episode, a course of antiviral medication is typically prescribed for 7 to 10 days. For people who experience recurrent outbreaks, shorter courses can be taken at the first sign of symptoms to limit the episode.
Because genital HSV-1 recurs less often than HSV-2, many people don’t need daily suppressive therapy. If outbreaks are infrequent (once a year or less), treating each episode individually as it arises is a common approach. For those who do experience more frequent recurrences or who want to minimize transmission risk to a partner, daily antiviral therapy is an option.
Genital HSV-1 During Pregnancy
Any type of genital herpes, whether caused by HSV-1 or HSV-2, poses a risk to a newborn during vaginal delivery. The greatest danger comes when a mother has an active outbreak with visible sores at the time of labor, or when she acquires a new genital herpes infection during the third trimester. A first infection late in pregnancy is particularly risky because the body hasn’t yet built up antibodies that help protect the baby.
If you have a history of genital herpes, sharing that with your prenatal care provider early in pregnancy allows for planning. Antiviral medication is commonly prescribed during the last month of pregnancy to reduce the likelihood of an outbreak around delivery. If active sores are present when labor begins, a cesarean delivery is recommended to avoid exposing the baby to the virus in the birth canal. For women who acquire genital herpes for the first time in the third trimester, cesarean delivery may also be offered even without visible sores, because the virus can shed for an extended period after a new infection.
Why the Distinction Between HSV-1 and HSV-2 Matters
Learning that your genital herpes is caused by HSV-1 rather than HSV-2 is generally reassuring news in practical terms. You’re likely to have fewer outbreaks, less frequent viral shedding between outbreaks, and a lower overall transmission risk to partners. None of this means the virus is harmless or that precautions aren’t needed, but it does change the day-to-day picture considerably compared to genital HSV-2.
The social reality is that HSV-1 is extremely common. Roughly half of American adults carry it, most of them orally. The rising prevalence of genital HSV-1 reflects shifting transmission patterns, not a new or different virus. Understanding which type you have helps you make informed decisions about treatment, disclosure, and sexual health going forward.